Raymond James & Associates’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $120K | Buy |
+42,062
| New | +$120K | ﹤0.01% | 3721 |
|
|
2022
Q1 | – | Sell |
-11,300
| Closed | -$33K | – | 4074 |
|
|
2021
Q4 | $33K | Buy |
+11,300
| New | +$33K | ﹤0.01% | 3900 |
|
|
2021
Q3 | – | Sell |
-92,900
| Closed | -$378K | – | 4055 |
|
|
2021
Q2 | $378K | Buy |
+92,900
| New | +$378K | ﹤0.01% | 3264 |
|
|
2020
Q4 | – | Sell |
-18,515
| Closed | -$110K | – | 3711 |
|
|
2020
Q3 | $110K | Buy |
+18,515
| New | +$110K | ﹤0.01% | 3324 |
|